annb0t
Top 20
Global Clinical Head Dr. Mukesh Ahuja Presented, "Injectable Pentosan Polysulfate Sodium for Knee Osteoarthritis: A Potential Disease-Modifying Osteoarthritis Drug."
NEW YORK, May 24, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals Ltd (ASX: PAR) ("Paradigm" or "the Company"), a clinical-stage biopharmaceutical company focused on repurposing existing molecules for new indications with unmet clinical needs, is honored that its Global Clinical Head of Osteoarthritis (OA) Mukesh Ahuja was selecte...
>>> Read more: PARADIGM BIOPHARMACEUTICALS SPOTLIGHTS POTENTIAL BREAKTHROUGH OSTEOARTHRITIS TREATMENT AT BIOLOGICAL ASSOCIATION 3RD ANNUAL SUMMIT
NEW YORK, May 24, 2022 /PRNewswire/ -- Paradigm Biopharmaceuticals Ltd (ASX: PAR) ("Paradigm" or "the Company"), a clinical-stage biopharmaceutical company focused on repurposing existing molecules for new indications with unmet clinical needs, is honored that its Global Clinical Head of Osteoarthritis (OA) Mukesh Ahuja was selecte...
>>> Read more: PARADIGM BIOPHARMACEUTICALS SPOTLIGHTS POTENTIAL BREAKTHROUGH OSTEOARTHRITIS TREATMENT AT BIOLOGICAL ASSOCIATION 3RD ANNUAL SUMMIT
